Figure 2.
Heatmap to summary the included literatures about the predictive value of lymphocyte subsets in the prediction of disease progression and response to anti-TNFα agents and vedolizumab. * represents the lymphocyte subgroups from the peripheral blood; # represents the lymphocyte subpopulations from the mucosal biopsy. One symbol (* or #) means there is one corresponding study.
